Patent details

EP3628049 Title: TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF

Basic Information

Publication number:
EP3628049
PCT Application Number:
US2018030816
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187942024
PCT Publication Number:
WO2018204594
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF
French Title of Invention:
PROTÉINES DE FUSION DU RÉCEPTEUR TGF-BÊTA DE TYPE II ET UTILISATIONS ASSOCIÉES
German Title of Invention:
FUSIONSPROTEINE VOM TGF-BETA-REZEPTOR TYP II UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
03/05/2018
Grant date:
10/05/2023
EP Publication Date:
01/04/2020
PCT Publication Date:
08/11/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/05/2023
EP B1 Publication Date:
10/05/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/05/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/05/2023
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
26/07/2023
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
SAKO, Dianne S.
Address:
United States (US)

2

Name:
KUMAR, Ravindra
Address:
United States (US)

Priority

1

Priority Number:
201762501229 P
Priority Date:
04/05/2017
Priority Country:
United States (US)

2

Priority Number:
201762510422 P
Priority Date:
24/05/2017
Priority Country:
United States (US)

3

Priority Number:
201762578674 P
Priority Date:
30/10/2017
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/71; C07K 16/46; A61K 38/17; A61P 9/12; A61P 9/10; A61P 13/12; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202319
Publication date:
10/05/2023
Description:
Grant (B1)

2

Issue number:
202324
Publication date:
14/06/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
10/04/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
26/07/2023 Power Of Attorney 1
26/07/2023 Outgoing Correspondence 1